Solid Biosciences (SLDB) Leases (2019 - 2024)
Solid Biosciences' Leases history spans 6 years, with the latest figure at $24.9 million for Q3 2024.
- For Q3 2024, Leases fell 8.57% year-over-year to $24.9 million; the TTM value through Sep 2024 reached $24.9 million, down 8.57%, while the annual FY2023 figure was $26.5 million, 8.32% down from the prior year.
- Leases for Q3 2024 was $24.9 million at Solid Biosciences, down from $25.5 million in the prior quarter.
- Across five years, Leases topped out at $28.9 million in Q4 2022 and bottomed at $722000.0 in Q1 2022.
- The 5-year median for Leases is $24.9 million (2024), against an average of $15.6 million.
- The largest annual shift saw Leases plummeted 77.41% in 2022 before it soared 3820.5% in 2023.
- A 5-year view of Leases shows it stood at $3.6 million in 2020, then crashed by 68.09% to $1.1 million in 2021, then skyrocketed by 2434.94% to $28.9 million in 2022, then fell by 8.32% to $26.5 million in 2023, then dropped by 6.33% to $24.9 million in 2024.
- Per Business Quant, the three most recent readings for SLDB's Leases are $24.9 million (Q3 2024), $25.5 million (Q2 2024), and $26.1 million (Q1 2024).